메뉴 건너뛰기




Volumn 19, Issue 56, 2000, Pages 6574-6583

From oncogene to drug: Development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

Author keywords

Anti angiogenesis; Anti tumor; Tyrosine kinase inhibitors

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CANERTINIB; ERLOTINIB; GEFITINIB; IMATINIB; LEFLUNOMIDE; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; PLATELET DERIVED GROWTH FACTOR INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; TERIFLUNOMIDE; TRASTUZUMAB; UNCLASSIFIED DRUG; VANDETANIB; VATALANIB;

EID: 0034722893     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204102     Document Type: Review
Times cited : (118)

References (83)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.